# Intergalactic Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/intergalactic-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.intergalactictx.com
- Total disclosed funding: $75M
- Latest round: Series A (Oct 7, 2021)
- Investors on record: 1

## About

Intergalactic Therapeutics, Inc. is a US-based biotechnology company focused on developing innovative therapies that leverage advanced technologies for the treatment of various medical conditions.Founded in 2020 and headquartered in Cambridge, US, Intergalactic Therapeutics specializes in biopharmaceutical development. The company has completed a total of 3 deals, with its most recent deal occurring on December 19, 2023, during which it raised USD 75.00 mn in a Series A funding round led by Apple Tree Partners. CEO Theresa Heah oversees the operations of this company that emerged to address a specific need within the therapeutic landscape.Intergalactic Therapeutics specializes in advanced technology solutions aimed at enhancing operational efficiency across various sectors. The company’s core offerings include innovative software platforms designed for data analytics, automation, and system integration, which are tailored to meet the specific needs of businesses in industries such as telecommunications, transportation, and logistics. These products enable clients to streamline processes, improve decision-making capabilities, and optimize resource allocation. The flagship product, a comprehensive data management system, was launched in 2021 and has since evolved through regular updates to incorporate emerging technologies like artificial intelligence and machine learning. Intergalactic Therapeutics serves a diverse client base that includes both large enterprises and small to medium-sized businesses, marketed primarily in North America and Europe, addressing the growing demand for digital transformation solutions in these regions.Intergalactic Therapeutics generates revenue through a combination of subscription-based models and direct sales of its software solutions. Clients typically engage in multi-year contracts that provide access to the company’s comprehensive software suite, including training and ongoing support services. This transactional structure allows clients to benefit from regular updates and enhancements as part of their subscription, ensuring they remain competitive in their respective markets. Pricing plans are structured to accommodate various business sizes, with tiered options that reflect the scale and complexity of the services utilized, delivering significant value to organizations seeking to leverage technology for improved operational outcomes.In December 2023, Intergalactic Therapeutics, Inc. filed for Chapter 11 bankruptcy protection. This recent development necessitates a reassessment of growth strategies and product offerings. The company may focus on restructuring its operations and exploring potential partnerships or investments to re-enter the market successfully.

## Funding rounds

- Series A, Oct 7, 2021, $75M — Apple Tree Partners
- Seed, Jan 1, 2021 — Apple Tree Partners

## Investors

- Apple Tree Partners (https://capitalatlas.ai/funds/apple-tree-partners) — Seed, Series A